Suchergebnisse - "Barlesi, Fabrice"

PubPharm (468)

1

The polarity and specificity of SARS-CoV2-specific T lymphocyte responses determine disease susceptibility

enthalten in: bioRxiv.org | 2024

von Fahrner, J. | Carrier, A. | De Sousa, E. | +52

2

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

3

STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Baptiste Oudart, J. | Garinet, S. | Leger, C. | +11

4

Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer : A Multiregional Chart Review in the United States, Europe, and Japan

enthalten in: JCO global oncology | 2024

von Leal, T. | Dasgupta, A. | Latremouille-Viau, D. | +4

5

Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small-cell lung cancer : a brief report from the CONVERT trial

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Walls, G. | Mistry, H. | Barlesi, F. | +6

6

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Khushalani, N. | Ott, P. | Ferris, R. | +16

7

TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Bessede, A. | Peyraud, F. | Besse, B. | +11

8

Correction : Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

enthalten in: Cell death & disease | 2024

von Danlos, F. | Grajeda-Iglesias, C. | Durand, S. | +37

ErratumFor: Cell Death Dis. 2021 Mar 11;12(3):258. - PMID 33707411

9

Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC : Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Reck, M. | Barlesi, F. | Yang, J. | +15

10

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC : A Phase 2 Randomized Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Vokes, E. | Mornex, F. | Sezer, A. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[47]